Adagene Inc. (ADAG)
NASDAQ·Healthcare·Biotechnology
$3.58
+0.00%
Mkt Cap $115.00M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+39.7%
Consensus $5.00 vs current $3.58
NASDAQ·Healthcare·Biotechnology
$3.58
+0.00%
Mkt Cap $115.00M
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
+39.7%
Consensus $5.00 vs current $3.58